Search

Your search keyword '"Panayiotides, Ioannis G"' showing total 269 results
Start Over Author "Panayiotides, Ioannis G"
269 results on '"Panayiotides, Ioannis G"'

1. Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Author

Abou-Foul, Ahmad K, Henson, Christina, Chernock, Rebecca D, Huang, Shao Hui, Lydiatt, William M, McDowell, Lachlan, O’Sullivan, Brian, Perez-Ordonez, Bayardo, Robinson, Max, Nankivell, Paul C, Ruiz-Bravo, Elena, Chiosea, Simion I, Green, Tina M, Hunter, Keith D, Hwang, Jacqueline SG, Koljenovic, Senada, Koppes, Sjors A, Larsen, Stine R, Lo, Anthony W I, Costes-Martineau, Valérie, Mittal, Neha, Mori, Taisuke, Nagao, Toshitaka, Panayiotides, Ioannis G, Pinto, Clóvis A L, Scheckenbach, Kathrin, Seethala, Raja R, Ulhøi, Benedicte P, Vingiani, Andrea, Zhang, Yan, Yom, Sue S, and Mehanna, Hisham

Published
2024
Full Text
View/download PDF

4. Artificial Intelligence and Image Analysis for the Identification of Endometrial Malignancies

Author

Pouliakis, Abraham, primary, Damaskou, Vasileia, additional, Margari, Niki, additional, Karakitsou, Efrossyni, additional, Pergialiotis, Vasilios, additional, Valasoulis, George, additional, Michail, George, additional, Chrelias, Charalampos, additional, Chrelias, George, additional, Sioulas, Vasileios, additional, Gouloumi, Alina-Roxani, additional, Koufopoulos, Nektarios, additional, Nifora, Martha, additional, Zacharatou, Andriani, additional, Kalantaridou, Sophia, additional, and Panayiotides, Ioannis G., additional

Published
2022
Full Text
View/download PDF

5. An Artificial Intelligence Approach for the Detection of Cervical Abnormalities

Author

Salamalekis, Evangelos, primary, Pouliakis, Abraham, additional, Margari, Niki, additional, Kottaridi, Christine, additional, Spathis, Aris, additional, Karakitsou, Effrosyni, additional, Gouloumi, Alina-Roxani, additional, Leventakou, Danai, additional, Chrelias, George, additional, Valasoulis, George, additional, Nasioutziki, Maria, additional, Kyrgiou, Maria, additional, Dinas, Konstantinos, additional, Panayiotides, Ioannis G, additional, Paraskevaidis, Evangelos, additional, and Chrelias, Charalampos, additional

Published
2022
Full Text
View/download PDF

6. The "Forgotten" Subtypes of Breast Carcinoma: A Systematic Review of Selected Histological Variants Not Included or Not Recognized as Distinct Entities in the Current World Health Organization Classification of Breast Tumors.

Author

Koufopoulos, Nektarios I., Boutas, Ioannis, Pouliakis, Abraham, Samaras, Menelaos G., Kotanidis, Christakis, Kontogeorgi, Adamantia, Dimas, Dionysios T., Ieronimaki, Argyro-Ioanna, Leventakou, Danai, Spathis, Aris, Zanelli, Magda, Palicelli, Andrea, Zizzo, Maurizio, Goutas, Dimitrios, Pateras, Ioannis S., and Panayiotides, Ioannis G.

Subjects
CELL differentiation, CANCER patients, BREAST tumors, TUMOR classification, CARCINOMA, BREAST
Abstract

Breast carcinoma is the most common cancer in women. Nineteen different subtypes of breast carcinomas are recognized in the current WHO classification of breast tumors. Except for these subtypes, there are a number of carcinomas with special morphologic and immunohistochemical features that are not included in the 5th WHO classification, while others are considered special morphologic patterns of invasive breast carcinoma of no special type. In this manuscript, we systematically review the literature on four different subtypes of invasive breast carcinoma, namely lymphoepithelioma-like breast carcinoma, breast carcinoma with osteoclast-like giant cells, signet-ring breast carcinoma, and metaplastic breast carcinoma with melanocytic differentiation. We describe their clinicopathological characteristics, focusing on the differential diagnosis, treatment, and prognosis. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. New Aspects and an Artificial Intelligence Approach for the Detection of Cervical Abnormalities

Author

Pouliakis, Abraham, primary, Valasoulis, George, additional, Michail, Georgios, additional, Salamalekis, Evangelos, additional, Margari, Niki, additional, Kottaridi, Christine, additional, Spathis, Aris, additional, Karakitsou, Effrosyni, additional, Gouloumi, Alina-Roxani, additional, Leventakou, Danai, additional, Chrelias, George, additional, Nasioutziki, Maria, additional, Kyrgiou, Maria, additional, Daponte, Alexandros I., additional, and Panayiotides, Ioannis G., additional

Published
2022
Full Text
View/download PDF

8. Diagnostic challenges during inflammation and cancer : current biomarkers and future perspectives in navigating through the minefield of reactive versus dysplastic and cancerous lesions in the digestive system

Author

Pateras, Ioannis S., Igea, Ana, Nikas, Ilias P., Leventakou, Danai, Koufopoulos, Nektarios I., Ieronimaki, Argyro Ioanna, Bergonzini, Anna, Ryu, Han Suk, Chatzigeorgiou, Antonios, Frisan, Teresa, Kittas, Christos, Panayiotides, Ioannis G., Pateras, Ioannis S., Igea, Ana, Nikas, Ilias P., Leventakou, Danai, Koufopoulos, Nektarios I., Ieronimaki, Argyro Ioanna, Bergonzini, Anna, Ryu, Han Suk, Chatzigeorgiou, Antonios, Frisan, Teresa, Kittas, Christos, and Panayiotides, Ioannis G.

Abstract

In the setting of pronounced inflammation, changes in the epithelium may overlap with neoplasia, often rendering it impossible to establish a diagnosis with certainty in daily clinical practice. Here, we discuss the underlying molecular mechanisms driving tissue response during persistent inflammatory signaling along with the potential association with cancer in the gastrointestinal tract, pancreas, extrahepatic bile ducts, and liver. We highlight the histopathological challenges encountered in the diagnosis of chronic inflammation in routine practice and pinpoint tissue-based biomarkers that could complement morphology to differentiate reactive from dysplastic or cancerous lesions. We refer to the advantages and limitations of existing biomarkers employing immunohistochemistry and point to promising new markers, including the generation of novel antibodies targeting mutant proteins, miRNAs, and array assays. Advancements in experimental models, including mouse and 3D models, have improved our understanding of tissue response. The integration of digital pathology along with artificial intelligence may also complement routine visual inspections. Navigating through tissue responses in various chronic inflammatory contexts will help us develop novel and reliable biomarkers that will improve diagnostic decisions and ultimately patient treatment.

Published
2024
Full Text
View/download PDF

9. Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System

Author

Pateras, Ioannis S., primary, Igea, Ana, additional, Nikas, Ilias P., additional, Leventakou, Danai, additional, Koufopoulos, Nektarios I., additional, Ieronimaki, Argyro Ioanna, additional, Bergonzini, Anna, additional, Ryu, Han Suk, additional, Chatzigeorgiou, Antonios, additional, Frisan, Teresa, additional, Kittas, Christos, additional, and Panayiotides, Ioannis G., additional

Published
2024
Full Text
View/download PDF

11. Cervical HPV Infections, Sexually Transmitted Bacterial Pathogens and Cytology Findings—A Molecular Epidemiology Study

Author

Valasoulis, George, primary, Pouliakis, Abraham, additional, Michail, Georgios, additional, Magaliou, Ioulia, additional, Parthenis, Christos, additional, Margari, Niki, additional, Kottaridi, Christine, additional, Spathis, Aris, additional, Leventakou, Danai, additional, Ieronimaki, Argyro-Ioanna, additional, Androutsopoulos, Georgios, additional, Panagopoulos, Periklis, additional, Daponte, Alexandros, additional, Tsiodras, Sotirios, additional, and Panayiotides, Ioannis G., additional

Published
2023
Full Text
View/download PDF

12. Malignant Brenner Tumor of the Ovary: A Systematic Review of the Literature.

Author

Koufopoulos, Nektarios I., Pouliakis, Abraham, Samaras, Menelaos G., Kotanidis, Christakis, Boutas, Ioannis, Kontogeorgi, Adamantia, Dimas, Dionysios, Sitara, Kyparissia, Zacharatou, Andriani, Ieronimaki, Argyro-Ioanna, Spathis, Aris, Leventakou, Danai, Zanelli, Magda, Pateras, Ioannis S., Panayiotides, Ioannis G., Palicelli, Andrea, and Syrios, John

Subjects
LYMPHADENECTOMY, RESEARCH funding, DESCRIPTIVE statistics, SYMPTOMS, BRENNER tumors, SYSTEMATIC reviews, MEDLINE, ONLINE information services, TUMOR antigens, OVARIES
Abstract

Simple Summary: Malignant Brenner tumors are rare ovarian neoplasms. Our aim is to provide insights concerning this rare entity. We reviewed 115 cases reported in the English literature until 15 September 2023, and analyzed the available demographic, clinical, and pathologic data. We also described the treatment modalities. A comparison of the available data showed that patients treated with lymph node dissection had a better disease-related survival rate. Disease recurrence was associated with tumor stage with marginal statistical significance and was more frequent in patients with ascites and those with abnormal CA-125 levels. Larger series with treatment details and long term follow-up data are needed to define the optimal management for this uncommon entity. Background: Malignant Brenner tumors are rare ovarian tumors, accounting for less than 1% of malignant ovarian neoplasms. The aim of this manuscript is to systematically review the current literature concerning malignant Brenner tumors. Methods: We searched three medical databases (PubMed, Scopus, and Web of Science) for relevant articles published until 15 September 2023. Results: After applying inclusion and exclusion criteria, 48 manuscripts describing 115 cases were included in this study from the English literature. Conclusions: We analyzed the demographic, clinical, pathological, and oncological characteristics of 115 patients with malignant Brenner tumors. The statistical analysis showed that recurrence was marginally statistically significantly related to tumor stage and was more common in patients with ascites and in women with abnormal CA-125 levels; patients that were treated with lymphadenectomy had better disease-specific survival. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases

Author

Zygouras, Ioannis, primary, Leventakou, Danai, additional, Pouliakis, Abraham, additional, Panagiotou, Styliana, additional, Tsakogiannis, Dimitris, additional, Konstantopoulos, Georgios, additional, Logotheti, Eirini, additional, Samaras, Menelaos, additional, Kyriakopoulou, Zaharoula, additional, Beloukas, Apostolos, additional, Pateras, Ioannis S., additional, Delides, Alexandros, additional, Psyrri, Amanda, additional, Panayiotides, Ioannis G., additional, Yiangou, Minas, additional, and Kottaridi, Christine, additional

Published
2023
Full Text
View/download PDF

14. FIGURE 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

15. FIGURE 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Materials and Methods from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 5 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 3 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 6 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

27. Data from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

28. FIGURE 2 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

30. TABLE 1 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, primary, Papaxoinis, George, primary, Economopoulou, Panagiota, primary, Kotsantis, Ioannis, primary, Gkotzamanidou, Maria, primary, Anastasiou, Maria, primary, Pectasides, Dimitrios, primary, Kyrodimos, Efthymios, primary, Delides, Alexander, primary, Giotakis, Evangelos, primary, Papadimitriou, Nikolaos G., primary, Panayiotides, Ioannis G., primary, Perisanidis, Christos, primary, Fernandez, Aileen I., primary, Xirou, Vasiliki, primary, Poulios, Christos, primary, Gagari, Eleni, primary, Yaghoobi, Vesal, primary, Gavrielatou, Niki, primary, Shafi, Saba, primary, Aung, Thazin Nwe, primary, Kougioumtzopoulou, Andromachi, primary, Kouloulias, Vassilis, primary, Palialexis, Konstantinos, primary, Gkolfinopoulos, Stavros, primary, Strati, Areti, primary, Lianidou, Evi, primary, Fountzilas, George, primary, Rimm, David L., primary, Foukas, Periklis G., primary, and Psyrri, Amanda, primary

Published
2023
Full Text
View/download PDF

32. Artificial Intelligence and Image Analysis for the Identification of Endometrial Malignancies

Author

Pouliakis, Abraham, primary, Damaskou, Vasileia, additional, Margari, Niki, additional, Karakitsou, Efrossyni, additional, Pergialiotis, Vasilios, additional, Valasoulis, George, additional, Michail, George, additional, Chrelias, Charalampos, additional, Chrelias, George, additional, Sioulas, Vasileios, additional, Gouloumi, Alina-Roxani, additional, Koufopoulos, Nektarios, additional, Nifora, Martha, additional, Zacharatou, Andriani, additional, Kalantaridou, Sophia, additional, and Panayiotides, Ioannis G., additional

Published
2020
Full Text
View/download PDF

33. Artificial Intelligence for the Identification of Endometrial Malignancies

Author

Pouliakis, Abraham, primary, Margari, Niki, additional, Karakitsou, Effrosyni, additional, Alamanou, Evangelia, additional, Koureas, Nikolaos, additional, Chrelias, George, additional, Sioulas, Vasileios, additional, Pappas, Asimakis, additional, Chrelias, Charalambos, additional, Terzakis, Emmanouil G, additional, Damaskou, Vasileia, additional, Panayiotides, Ioannis G, additional, and Karakitsos, Petros, additional

Published
2020
Full Text
View/download PDF

35. Primary Adrenal Lymphomas with Cushing’s Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells

Author

Papageorgiou, Sotirios G., primary, Mavroeidi, Ioanna, additional, Kostakis, Marios, additional, Spathis, Aris, additional, Leventakou, Danai, additional, Kritikou, Evangelia, additional, Oikonomopoulos, Nikolaos, additional, Kourkouti, Chrysoula, additional, Krania, Maria, additional, Bouchla, Anthi, additional, Thomopoulos, Thomas, additional, Tsakiraki, Zoi, additional, Markakis, Konstantinos, additional, Panayiotides, Ioannis G., additional, Thomaidis, Nikolaos, additional, Pappa, Vasiliki, additional, Foukas, Periklis G., additional, and Peppa, Melpomeni, additional

Published
2023
Full Text
View/download PDF

36. Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer

Author

Moutafi, Myrto, primary, Koliou, Georgia-Angeliki, additional, Papaxoinis, George, additional, Economopoulou, Panagiota, additional, Kotsantis, Ioannis, additional, Gkotzamanidou, Maria, additional, Anastasiou, Maria, additional, Pectasides, Dimitrios, additional, Kyrodimos, Efthymios, additional, Delides, Alexander, additional, Giotakis, Evangelos, additional, Papadimitriou, Nikolaos G., additional, Panayiotides, Ioannis G., additional, Perisanidis, Christos, additional, Fernandez, Aileen I., additional, Xirou, Vasiliki, additional, Poulios, Christos, additional, Gagari, Eleni, additional, Yaghoobi, Vesal, additional, Gavrielatou, Niki, additional, Shafi, Saba, additional, Aung, Thazin Nwe, additional, Kougioumtzopoulou, Andromachi, additional, Kouloulias, Vassilis, additional, Palialexis, Konstantinos, additional, Gkolfinopoulos, Stavros, additional, Strati, Areti, additional, Lianidou, Evi, additional, Fountzilas, George, additional, Rimm, David L., additional, Foukas, Periklis G., additional, and Psyrri, Amanda, additional

Published
2023
Full Text
View/download PDF

37. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study

Author

Gkolfakis, Paraskevas, primary, Tziatzios, Georgios, additional, Leite, Gabriela, additional, Papanikolaou, Ioannis S., additional, Xirouchakis, Elias, additional, Panayiotides, Ioannis G., additional, Karageorgos, Athanasios, additional, Millan, Maria Jesus, additional, Mathur, Ruchi, additional, Weitsman, Stacy, additional, Dimitriadis, George D., additional, Giamarellos-Bourboulis, Evangelos J., additional, Pimentel, Mark, additional, and Triantafyllou, Konstantinos, additional

Published
2023
Full Text
View/download PDF

40. Diffuse panniculitis in a teen male with ZZ alpha1-antitrypsin deficiency

Author

Papiris, Spyros A., primary, Parmaxidis, Anthimos, additional, Theotokoglou, Sofia, additional, Tsakiraki, Zoe, additional, Veith, Martina, additional, Panagiotou, Aikaterini, additional, Pappa, Vasiliki, additional, Kallieri, Maria, additional, Mornex, Jean-François, additional, Katoulis, Alexander C., additional, Haritos, Dionysios, additional, Panayiotides, Ioannis G., additional, and Manali, Effrosyni D., additional

Published
2023
Full Text
View/download PDF

41. Diagnostically Challenging Subtypes of Invasive Lobular Carcinomas: How to Avoid Potential Diagnostic Pitfalls

Author

Koufopoulos, Nektarios, primary, Pateras, Ioannis S., additional, Gouloumis, Alina Roxana, additional, Ieronimaki, Argyro Ioanna, additional, Zacharatou, Andriani, additional, Spathis, Aris, additional, Leventakou, Danai, additional, Economopoulou, Panagiota, additional, Psyrri, Amanda, additional, Arkadopoulos, Nikolaos, additional, and Panayiotides, Ioannis G., additional

Published
2022
Full Text
View/download PDF

45. Erdheim–Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report

Author

Papageorgiou, Sotirios G, Divane, Aspasia, Roumelioti, Maria, Kottaridi, Christine, Bouchla, Anthi, Georgakopoulos, Alexandros, Ieremiadou, Fotini, Daraki, Aggeliki, Bazani, Efthymia, Thomopoulos, Thomas P, Chatziioannou, Sofia, Mavrogenis, Andreas, Panayiotidis, Panayiotis, Panayiotides, Ioannis G, Pappa, Vasiliki, and Foukas, Periklis G

Subjects
midostaurin, genetic structures, molecular karyotype, Erdheim–Chester disease, clonal hematopoiesis, case report, acute myeloid leukemia
Abstract

Background Erdheim–Chester Disease (ECD) is a clonal non-Langerhans histiocytosis, classified as a macrophage-dendritic cell neoplasm in the 2016 WHO classification. The exact cell of origin of ECD is unknown, although some limited evidence suggests that it arises from myeloid progenitors. Case Presentation A 43-year-old patient, diagnosed with BRAFV600E mutated ECD, developed NPM1+/FLT3+ acute myeloid leukemia (AML) with wild-type BRAF, 15 months after the initial ECD diagnosis. The patient received intensive chemotherapy plus midostaurin, followed by midostaurin maintenance. Six months into maintenance, the patient remains in complete remission with low-level measurable residual disease, whereas ECD shows a sustained partial metabolic response. Molecular karyotype at several distinct timepoints, namely ECD diagnosis, AML diagnosis, and following treatment of AML, highlighted a molecular signature, indicative of a persistent, underlying clonal hematopoiesis. Conclusion This case report suggests that ECD and AML might represent an expansion of two distinct clones in a background of clonal hematopoiesis, indicating their shared origin. Moreover, molecular karyotype might serve as a strong, inexpensive tool for revealing clonal hematopoiesis in cases of negative targeted next-generation sequencing. Finally, the moderate response of ECD to midostaurin suggests that kinase inhibition might have a potential role in ECD treatment.

Published
2020

50. COVID-19 Pandemic and Environmental Health: Effects and the Immediate Need for a Concise Risk Analysis

Author

Maipas, Sotirios Panayiotides, Ioannis G. Tsiodras, Sotirios and Kavantzas, Nikolaos

Abstract

COVID-19 pandemic, as another disease emerging in the interface between animals and humans, has revealed the importance of interdisciplinary collaborations such as the One Health initiative. Environmental Health, whose role in the One Health concept is well established, has been associated with COVID-19 pandemic via various direct and indirect pathways. Modern lifestyle, climate change, environmental degradation, exposure to chemicals such as endocrine disruptors, and exposure to psychological stress factors impact human health negatively. As a result, many people are in the disadvantageous position to face the pandemic with an already impaired immune system due to their exposure to environmental health hazards. Moreover, the ongoing pandemic has been associated with outdoor and indoor air pollution, water and noise pollution, food security, and plastic pollution issues. Also, the inadequate infrastructure, the lack of proper waste and wastewater management, and the unequal social vulnerability reveal more linkages between Environmental Health and COVID-19 pandemic. The significant emerging ecological risk and its subsequent health implications require immediate risk analysis and risk communication strategies.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results